We are live on ! Find out more
CMD

Cantel Medical Corporation
CMD

Delisted

CMD was delisted on the 1st of June, 2021.

172 hedge funds and large institutions have $1.95B invested in Cantel Medical Corporation in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 56 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

13% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 56

6% more funds holding

Funds holding: 163172 (+9)

5% more capital invested

Capital invested by funds: $1.85B → $1.95B (+$96.7M)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

Holders
172
Holders Change
+9
Holders Change %
+5.52%
% of All Funds
4.8%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.17%
New
24
Increased
63
Reduced
56
Closed
12
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
1
Brown Capital Management
Maryland
$322M +$3.12M +58,932 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$143M +$2.37M +44,682 +2%
BFA
3
BlackRock Fund Advisors
California
$124M +$3.54M +66,844 +3%
EARNEST Partners
4
EARNEST Partners
Georgia
$117M -$5.35M -101,053 -5%
DM
5
Diker Management
New York
$115M -$1.01M -19,148 -0.9%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$75.3M +$1.74M +32,891 +3%
New York State Common Retirement Fund
7
New York State Common Retirement Fund
New York
$73M -$3.36M -63,463 -5%
CCA
8
Conestoga Capital Advisors
Pennsylvania
$53.8M -$1.64M -30,891 -3%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$48.4M -$1.27M -23,977 -3%
BIT
10
BlackRock Institutional Trust
California
$48.4M -$863K -16,298 -2%
CIP
11
Champlain Investment Partners
Vermont
$47.8M +$392K +7,395 +0.9%
Northern Trust
12
Northern Trust
Illinois
$42.4M +$592K +11,186 +2%
BAMCO Inc
13
BAMCO Inc
New York
$39.7M
State Street
14
State Street
Massachusetts
$37.9M -$179K -3,375 -0.5%
Neuberger Berman Group
15
Neuberger Berman Group
New York
$32.8M +$3.49M +65,844 +13%
O
16
OppenheimerFunds
New York
$31.9M +$3.95M +74,660 +15%
RIM
17
Ranger Investment Management
Texas
$31.9M -$747K -14,102 -2%
TA
18
Teton Advisors
New York
$29.6M -$344K -6,500 -1%
GKIM
19
GW&K Investment Management
Massachusetts
$29.3M +$506K +9,553 +2%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$26M +$3.63M +68,623 +18%
Janus Henderson Group
21
Janus Henderson Group
United Kingdom
$25.9M +$501K +9,467 +2%
Public Employees Retirement Association of Colorado
22
Public Employees Retirement Association of Colorado
Colorado
$22.5M
Norges Bank
23
Norges Bank
Norway
$20.6M
NFA
24
Nationwide Fund Advisors
Ohio
$20.1M +$9.58M +180,955 +105%
Ameriprise
25
Ameriprise
Minnesota
$18.8M -$171K -3,223 -1%

CMD Hedge Fund Activity: Q3 2015 in Review

172 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q3 2015, worth a combined $1.95B — up 5.2% from $1.85B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CMD positions and 12 closed out — a net gain of 12 holders — while 63 added to existing stakes and 56 trimmed.

The largest buyer was Nationwide Fund Advisors, adding an estimated $9.58M. The largest seller was Impax Asset Management, exiting entirely with an estimated $8.97M sold.

  • 172 institutional investors held Cantel Medical Corporation (CMD) as of Q3 2015, up from 163 in Q2 2015.
  • Funds reported $1.95B of Cantel Medical Corporation stock for Q3 2015, up 5.2% quarter-over-quarter.
  • 24 funds opened new Cantel Medical Corporation positions in Q3 2015 and 12 closed out, a net change of +12 holders.
  • The largest Cantel Medical Corporation buyer in Q3 2015 was Nationwide Fund Advisors, an estimated $9.58M added.
  • The largest Cantel Medical Corporation seller in Q3 2015 was Impax Asset Management, an estimated $8.97M sold.

Based on aggregated 13F filings for Q3 2015.